Navigation Links
HerbalScience Research Identifies Key Bioactives in Nettle Extract That Inhibit Inflammation Associated with Seasonal Allergies
Date:8/26/2009

NAPLES, Fla., Aug. 26 /PRNewswire/ -- Most people might think of nettle as simply a common and aggressive weed that can sting and cause skin irritation. But nettle has also been used for hundreds of years to treat seasonal allergies and other inflammatory diseases, although the precise nature of its anti-inflammatory effect was unknown. Now, scientists with HerbalScience have identified specific bioactives in nettle leaf extracts that inhibit in vitro receptors and enzymes known to be key in generating symptoms of allergic rhinitis, or hay fever.

An article detailing the research, titled "Nettle Extract (Urtica dioica) Affects Key Receptors and Enzymes Associated with Allergic Rhinitis," has been published in the July 2009 issue of Phythotherapy Research, a peer-reviewed scientific journal. The authors are affiliated with HerbalScience Group LLC, a Naples, Florida, and Singapore-based company dedicated to applying advanced science and technology to the production of botanical drugs and nutraceuticals, and the University of Miami Leonard M. Miller School of Medicine, Miami, Florida.

"More than 20 million people in the United States suffer from seasonal allergies," said Randall S. Alberte, Ph.D., Chief Scientific Officer of HerbalScience and one of the authors of the published study. "While there are many effective over-the-counter and prescription allergy medications on the market, the fact that some may cause undesirable side effects in some patients means there is an ongoing need to seek potential new treatments. Our research results provide, for the first time, an understanding of how nettle extracts reduce allergic responses in vitro, which could lead to new standardized botanical, non-drug therapies that are safe and effective, and that have no side effects."

The study utilized a proprietary nettle extract prepared using HerbalScience's p
'/>"/>

SOURCE HerbalScience
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. HerbalScience Research Identifies Specific Bioactives In Stabilized Rice Bran Extract that Impart Anti-Inflammatory Benefits
2. NutraCea Forms Joint Ventures With HerbalScience to Develop Nutraceutical Extracts and Pharmaceutical Chemistries From Stabilized Rice Bran
3. Researchers evaluate resistance training for diabetes prevention
4. Nottingham scientists commissioned for urgent swine flu research
5. Consumers Research Council of America Names Plastic Surgeon Oleh S. Slupchynskyj, M.D. as One of Americas Top Surgeons for the Second Time
6. Large National Cancer Research Center Selects ATCis Simulsat C/Ku Broadcast System for Headquarters
7. NIAID to fund new human immune profiling research centers
8. Researchers find that employees who are engaged in their work have happier home life
9. New research: Consumption of sugar substitutes assists in long-term weight control
10. U-M researchers discover therapeutic target that could help patients with pulmonary fibrosis
11. Advances in lung cancer research announced at conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... New York (PRWEB) September 18, 2014 ... report published by Transparency Market Research "Pipeline ... (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, ... Share, Growth, Trends and Forecast 2014 - ... total revenue of USD 3.8 billion by ...
(Date:9/18/2014)... MD (PRWEB) September 18, 2014 ... are pleased to announce the release of Activz ... the nutrient-rich liquid of young, organic coconuts from Thailand. ... the highly-acclaimed Activz Whole-Food Nutrition revolutionary line of produce ... and grass options. The new Activz Coconut Water ...
(Date:9/18/2014)... By Dennis Thompson ... -- There is little evidence that testosterone replacement therapy ... American males, a U.S. Food and Drug Administration advisory panel ... overwhelmingly voted, 20-1, to tighten use of the popular drugs ... risk of heart attack and stroke, according to Bloomberg ...
(Date:9/18/2014)... Individuals living in disadvantaged neighborhoods have worse musculoskeletal ... as motor vehicle collision than individuals from higher ... characteristics such as age, sex, income, education, and ... a multi-site research study led by Samuel McLean, ... medicine at the University of North Carolina School ...
(Date:9/18/2014)... 2014 CRDF Global released today ... digital edition – rich with videos, images and ... CRDF Global empowers scientists and innovators around the ... corporate, foundation and individual supporters, CRDF Global reaches ... research, training and entrepreneurship. , The Annual Report ...
Breaking Medicine News(10 mins):Health News:Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Reveals Six Potential Late Stage Candidates and Ten Late Stage Candidates: Transparency Market Research 2Health News:Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Reveals Six Potential Late Stage Candidates and Ten Late Stage Candidates: Transparency Market Research 3Health News:Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Reveals Six Potential Late Stage Candidates and Ten Late Stage Candidates: Transparency Market Research 4Health News:New Activz Organic Coconut Water Powder Announced at Natural Products Expo East 2Health News:New Activz Organic Coconut Water Powder Announced at Natural Products Expo East 3Health News:FDA Panel: Limit Testosterone Drug Use 2Health News:FDA Panel: Limit Testosterone Drug Use 3Health News:FDA Panel: Limit Testosterone Drug Use 4Health News:Living in a disadvantaged neighborhood worsens musculoskeletal pain outcomes after trauma 2Health News:CRDF Global Launches Media-Rich Digital Edition of Annual Report, Tells Story of Empowering Scientists and Innovators around the World in 2013 2
... the Closet, Thrift Store, Non-profit,AHF Pharmacy, Offers HIV/AIDS Expertise, ... Grand Opening Event to Include Ribbon-Cutting Ceremony, Free ... February,2nd at 10:00 a.m., AIDS Healthcare Foundation (AHF) will ... grand opening event to include,a ribbon-cutting ceremony and free ...
... is enthused about Part D,s success, but critics say ... -- The three-year-old Medicare Part D drug program is ... costs for the program fall, U.S. health officials announced ... considerably lower than originally projections, enrollment continues to rise ...
... romiplostim (Nplate) show that it significantly improved platelet levels ... hematologic disorder that can cause uncontrolled bleeding. An ... the drug, which duplicates the action of a natural ... in the February 2 issue of The Lancet. ...
... NEW YORK, Jan. 31 QED International Associates, ... 20 underlying,indexes for the HealthShares(TM) Exchange-Traded Funds, today ... Monday February 4, 2008,BioMerieux Worldwide (Euronext: BIM) will ... European Medical Products and Devices Index., Companies ...
... Lead Sponsor in Karmanos Cancer Institute,s Annual Dinner, ... Barbara Ann Karmanos,Cancer Institute will upgrade its nurse ... Company Fund, according to Nick Karmanos, vice,president of ... ), "As Lead Sponsor for our 26th ...
... guidelines say differences between nonprofit, for-profit banks should be ... Doctors should tell pregnant patients considering umbilical cord blood ... private cord blood banks, new guidelines state. , The ... revised Committee Opinion in the February issue of ...
Cached Medicine News:Health News:West Hollywood: AHF Hosts Grand Opening of HIV/AIDS Pharmacy that Benefits AIDS Patients Worldwide 2Health News:West Hollywood: AHF Hosts Grand Opening of HIV/AIDS Pharmacy that Benefits AIDS Patients Worldwide 3Health News:Medicare's Drug Program Enrollment Up, Costs Down 2Health News:Medicare's Drug Program Enrollment Up, Costs Down 3Health News:Drug-based on MGH discovery may significantly improve treatment of dangerous blood disorder 2Health News:Ford Motor Company Fund Continues Longtime Support to Cancer Care 2Health News:Docs Should Tell All About Cord Blood Banks 2
(Date:9/18/2014)... , Sept. 18, 2014 Australian biomarker discovery ... US trial of its MiStat™ prostate cancer screening test, ... regulatory approval upon completion. Minomic,s proprietary MiStat™ ... presence of a proprietary biomarker known as the MIL-38 ... prostate cancer cells. Researchers at 11 ...
(Date:9/18/2014)... LA JOLLA, Calif. , Sept. 18, 2014 ... RGLS ), a biopharmaceutical company leading the ... announced today it has initiated its ATHENA natural ... syndrome, a life-threatening genetic kidney disease with no ... characterize the natural decline of renal function markers ...
(Date:9/18/2014)... , Sept. 18, 2014   Auxilium ... a specialty biopharmaceutical company, today announced the first ... the AUX-CC-867 MULTICORD (MULtiple Treatment Investigation of Collagenase ... This study evaluated collagenase clostridium histolyticum (CCH) for ... the same hand. In addition, the study examined ...
Breaking Medicine Technology:Minomic Launches US Pilot Study of MiStat(TM) Novel Prostate Cancer Screening Technology 2Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 2Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 3Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 4Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 5Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 6Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 2Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 3Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 4Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 5Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 6Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 7
... Intellect Neurosciences, Inc. (OTCBB: ILNS), a biopharmaceutical company ... therapeutic agents for the treatment of Alzheimer,s and ... filed a response and request for continued examination ... 10/084,380, one of several applications pending in the ...
... VIEW, Calif., Nov. 3, 2011 VIVUS, Inc. (NASDAQ: ... chief financial officer, will present an overview of the ... The VIVUS presentation will take place at the ... at 9:30 a.m. MST.  A live webcast and 30-day ...
Cached Medicine Technology:Intellect Neurosciences Responds to Official Action by United States Patent and Trademark Office in Relation to its ANTISENILIN® Alzheimer's Patent Application 2Intellect Neurosciences Responds to Official Action by United States Patent and Trademark Office in Relation to its ANTISENILIN® Alzheimer's Patent Application 3
5x6mm Loop, 2 Irrigation Ports at 10, 2 O'Clock, 18 Gauge Thin Walled 1.2mm Shaft; overall length 40mm; stainless steel...
... long, thick-walled cannula which contains a coaxial ... Helical Loop Basket and a Tip Deflecting ... the outer cannula to carry these two ... right atrium. (Requires a Handle for Tip ...
... a non-invasive, virtually pain-free alternative to conventional ... selected indications. With Leksell Gamma Knife C ... positioning improves the ability to mould the ... This allows a more selective irradiation and ...
Clinac Platinum Plus accelerators offer all the high performance features of the EX series and come with the latest high-precision dose sculpting technology for advanced tumor control....
Medicine Products: